In CCl4-induced liver fibrosis mice, intravenously injected mouse BM-MSCs successfully migrated to the damaged liver and significantly relieved liver fibrosis by decreasing IL-17 and increasing IL-10 [86]. Here, IL17A is linked to Hepatic fibrosis.